Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,588 | 149,750 | 135,551 | 111,800 | 172,377 |
| Marketable Securities | 344,568 | 261,011 | 232,670 | 243,425 | 190,885 |
| Receivables | 53,837 | 61,518 | 41,123 | 34,626 | 32,553 |
| Inventories | 8,350 | 7,190 | 7,730 | 7,513 | 6,915 |
| Other current assets | 0 | 0 | 14,000 | 14,000 | 14,000 |
| TOTAL | $560,846 | $503,367 | $458,636 | $431,527 | $432,588 |
| Non-Current Assets | |||||
| PPE Net | 1,472 | 127 | 195 | 302 | 413 |
| Investments And Advances | 19,315 | 40,276 | 57,176 | 59,621 | 0 |
| Other Non-Current Assets | 132,922 | 112,165 | 105,510 | 102,572 | 91,624 |
| TOTAL | $153,709 | $152,568 | $162,881 | $162,495 | $92,037 |
| Total Assets | $714,555 | $655,935 | $621,517 | $594,022 | $524,625 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,484 | 12,557 | 17,396 | 16,710 | 7,976 |
| Accrued Expenses | 21,972 | 24,825 | 72,958 | 21,305 | 18,607 |
| Other current liabilities | N/A | N/A | 14,000 | 14,000 | 14,000 |
| TOTAL | $100,750 | $97,202 | $104,505 | $121,873 | $93,059 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,625 | 0 | 0 | 0 | 0 |
| TOTAL | $17,562 | $10,869 | $10,307 | $10,470 | $9,952 |
| Total Liabilities | $118,312 | $108,071 | $114,812 | $132,343 | $103,011 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,493 | 104,112 | 103,517 | 103,081 | 102,547 |
| Common Shares | 134 | 133 | 133 | 133 | 132 |
| Retained earnings | 465,776 | 430,288 | 402,526 | 371,171 | 339,793 |
| Other shareholders' equity | 321 | 199 | 531 | -22 | -29 |
| TOTAL | $596,243 | $547,864 | $506,705 | $461,679 | $421,614 |
| Total Liabilities And Equity | $714,555 | $655,935 | $621,517 | $594,022 | $524,625 |